Balaxi Pharmaceuticals fundamental analysis

BALAXI

21.12

2.32 (12.34%)
Last updated on 2 Apr, 2026 | 15:54 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Balaxi Pharmaceuticals Fundamentals

P/E Ratio

10.99

P/B Ratio

0.44

Div. Yield

0

Sector P/E

37.04

Sector P/B

1.91

Sec. Div. Yield

82.37

Balaxi Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 10.99, compared to the sector average of 37.04. Its P/B Ratio stands at 0.44, while the sector’s is 1.91. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 82.37%.

Balaxi Pharmaceuticals Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Moderate

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Balaxi Pharmaceuticals reflects: Price – Attractive, Growth – Moderate, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost